Search

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.

Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

How will new guidance issued by the FDA affect drug importation?

A typical vaccine takes around 10 to 12 years to reach the market. A key question: “Where should we base production?”

Sitting Down With… Richard M. Johnson, President, and Chief Executive Officer, Parenteral Drug Association.